Delivery Order SPE2DB22D2007-SPE2DB23FJ4RF
Award Date 8/1/23
Potential Completion Date 8/22/23
Potential Value $17K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $6,007.90 to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (28-count packaging) with a firm fixed price structure. This non-set-aside contract was awarded on July 30, 2025, with an ultimate completion date of August 20, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a single transaction under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $6,007.90 to AmerisourceBergen Drug Corp for the supply of Tasigna 150 mg capsules (28-count units) under a firm fixed price contract. This non-competitive delivery order, issued on August 8, 2025, with an ultimate completion date of August 29, 2025, will be performed at the awardee's facility in Conshohocken, Pennsylvania. Tasigna is a specialized oncology medication used in the treatment of certain types of leukemia, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $6,007.90 to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (28-count units) on July 23, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Tasigna is a specialized oncology medication used in the treatment of chronic myeloid leukemia, reflecting the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,015.80 to AmerisourceBergen Drug Corp for the supply of Tasigna 150 mg capsules (28-count units) under a firm fixed price contract. The award was made on August 12, 2025, with an ultimate completion date of September 3, 2025, and does not utilize a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a $16,873.86 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 28 capsules of the cancer drug TASIGNA 200 MG. The order is under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to the Department of Defense. Amerisourcebergen will fulfill the order from its facility located in Conshohocken, Pennsylvania by July 31, 2023 to support the DLA's mission to provide logistics support...
- The Defense Logistics Agency awarded a $6,007.90 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Tasigna 150 mg capsules (28-count packages). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The contract will be completed by September 2, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $16,873.86 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 28 capsules of the pharmaceutical TASIGNA 150 MG. To be performed in Conshohocken, Pennsylvania under contract number 4562389115 from September 28, 2023 through October 20, 2023, this order is likely placed against DLA's Pharmaceutical Prime Vendor contract to support the Department of Defense's medical supply needs. No subcontractors or set aside...
- The Defense Logistics Agency Troop Support Medical awarded a $5,624.62 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 28 capsules of 150mg Tasigna, an oncology medication. The delivery order was issued against an existing prime vendor contract vehicle and requires Amerisourcebergen to provide the medication from its facility in Conshohocken, Pennsylvania to an unspecified customer by July 31, 2023. No subcontractors or set aside designations were...
- The Defense Logistics Agency awarded a $6,007.90 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Tasigna 150 mg capsules (quantity: 28 units) on August 15, 2025, with an ultimate completion date of September 8, 2025. This non-set-aside delivery order represents a competitive award under the company's broader pharmaceutical supply relationship with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,007.90 to AmerisourceBergen Drug Corp for the supply of Tasigna 150 mg capsules (28-count packaging). This contract is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The order is scheduled for completion by September 3, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB23FJ4RFDelivery Order
The Defense Logistics Agency awarded a $16,873.86 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 28 capsules of the cancer drug Tasigna (nilotinib) 150 mg. The order is being fulfilled under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Amerisourcebergen will deliver the Tasigna capsules to the specified location in Conshohocken, Pennsylvania by August 22, 2023 to support the DLA and DoD's medical readiness and treatment programs. No subcontractors or set aside designations were identified in the award information.
Generated 12/19/23, 8:44 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.9k | 8/1/23 |